Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bacillus subtilis is a probiotic bacterium that has drawn scientific interest for its potential role in supporting metabolic health, including aspects of Metabolic Syndrome (MetS). Metabolic Syndrome is a cluster of risk factors—such as abdominal obesity, dyslipidemia, hypertension, and insulin resistance—that increase the likelihood of cardiovascular disease and type 2 diabetes.

Recent preclinical and some early human studies suggest that Bacillus subtilis supplementation may influence metabolic parameters. In animal models, administration of B. subtilis has been associated with improvements in glucose tolerance, reductions in serum triglycerides, and modulation of inflammation—all of which are relevant to MetS. The proposed mechanisms include enhancement of gut barrier function, modulation of the gut microbiota, production of beneficial metabolites (like short-chain fatty acids), and immune system regulation.

A limited number of small-scale human trials and pilot studies have reported beneficial effects of B. subtilis-based probiotics on glycemic control and lipid profiles, but the evidence is not yet robust or consistent. Larger, well-designed randomized controlled trials are still needed to confirm efficacy and safety in patients with Metabolic Syndrome.

In summary, Bacillus subtilis is being explored as a probiotic intervention for Metabolic Syndrome based on emerging scientific evidence, but current support is preliminary and not yet definitive. The current evidence base justifies a moderate but cautious rating (2/5) for its use in this context.

More about bacillus subtilis
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by bacillus subtilis

Products containing bacillus subtilis

Nature's Sunshine AIVIA Performance Probiotic